These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10585634)

  • 1. Transforming growth factor beta activity in urine of patients with type 2 diabetes and diabetic nephropathy.
    Rivarola EW; Moyses-Neto M; Dantas M; Da-Silva CG; Volpini R; Coimbra TM
    Braz J Med Biol Res; 1999 Dec; 32(12):1525-8. PubMed ID: 10585634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased excretion of urinary transforming growth factor beta 1 in patients with diabetic nephropathy.
    Sato H; Iwano M; Akai Y; Kurioka H; Kubo A; Yamaguchi T; Hirata E; Kanauchi M; Dohi K
    Am J Nephrol; 1998; 18(6):490-4. PubMed ID: 9845822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevation of urinary betaig-h3, transforming growth factor-beta-induced protein in patients with type 2 diabetes and nephropathy.
    Ha SW; Kim HJ; Bae JS; Jeong GH; Chung SC; Kim JG; Park SH; Kim YL; Kam S; Kim IS; Kim BW
    Diabetes Res Clin Pract; 2004 Aug; 65(2):167-73. PubMed ID: 15223229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Urine TGF-beta1 concentration in patients with type II diabetes mellitus--prognostic values].
    Paczek L; Kropiewnicka HE; Senatorski G; Bartłomiejczyk I
    Pol Arch Med Wewn; 2002 Aug; 108(2):745-52. PubMed ID: 12476894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pioglitazone reduces urinary protein and urinary transforming growth factor-beta excretion in patients with type 2 diabetes and overt nephropathy.
    Katavetin P; Eiam-Ong S; Suwanwalaikorn S
    J Med Assoc Thai; 2006 Feb; 89(2):170-7. PubMed ID: 16579002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary concentration of transforming growth factor-beta-inducible gene-h3(beta ig-h3) in patients with Type 2 diabetes mellitus.
    Cha DR; Kim IS; Kang YS; Han SY; Han KH; Shin C; Ji YH; Kim NH
    Diabet Med; 2005 Jan; 22(1):14-20. PubMed ID: 15606685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytokines in noninvasive diagnostics of diabetic nephropathy progression].
    Senatorski G; Paczek L; Kropiewnicka E; Bartłomiejczyk I
    Pol Merkur Lekarski; 2002 Nov; 13 Suppl 1():28-32. PubMed ID: 12621778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Increased urinary excretion of transforming growth factor beta and interleukin-6 in patients with diabetic nephropathy].
    Królak R; Paczek L; Rogala H; Bartłomiejczyk I; Gradowska L; Korczak D; Gaciong Z
    Pol Arch Med Wewn; 1996 Dec; 96(6):545-51. PubMed ID: 9139274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular basis of diabetic nephropathy: II. The transforming growth factor-beta system and diabetic nephropathy lesions in type 1 diabetes.
    Huang C; Kim Y; Caramori ML; Fish AJ; Rich SS; Miller ME; Russell GB; Mauer M
    Diabetes; 2002 Dec; 51(12):3577-81. PubMed ID: 12453917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Oral carnosine supplementation on urinary TGF-β in diabetic nephropathy: a randomized controlled trial.
    Siriwattanasit N; Satirapoj B; Supasyndh O
    BMC Nephrol; 2021 Jun; 22(1):236. PubMed ID: 34174842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of urinary TGF-β1 in patients with diabetes mellitus and normal controls.
    Tsapenko MV; Nwoko RE; Borland TM; Voskoboev NV; Pflueger A; Rule AD; Lieske JC
    Clin Biochem; 2013 Oct; 46(15):1430-5. PubMed ID: 23685222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-beta(1) in the kidney and urine of patients with glomerular disease and proteinuria.
    Goumenos DS; Tsakas S; El Nahas AM; Alexandri S; Oldroyd S; Kalliakmani P; Vlachojannis JG
    Nephrol Dial Transplant; 2002 Dec; 17(12):2145-52. PubMed ID: 12454225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary excretion of TGF-beta 1, PDGF-BB and fibronectin in insulin-dependent diabetes mellitus patients.
    Fagerudd JA; Groop PH; Honkanen E; Teppo AM; Grönhagen-Riska C
    Kidney Int Suppl; 1997 Dec; 63():S195-7. PubMed ID: 9407457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary transforming growth factor-beta 1 in various types of nephropathy.
    De Muro P; Faedda R; Fresu P; Masala A; Cigni A; Concas G; Mela MG; Satta A; Carcassi A; Sanna GM; Cherchi GM
    Pharmacol Res; 2004 Mar; 49(3):293-8. PubMed ID: 14726227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of enalapril and losartan on the events that precede diabetic nephropathy in rats.
    Volpini RA; da Silva CG; Costa RS; Coimbra TM
    Diabetes Metab Res Rev; 2003; 19(1):43-51. PubMed ID: 12592643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor beta 1 and monocyte chemoattractant protein-1 as prognostic markers of diabetic nephropathy.
    Shaker OG; Sadik NA
    Hum Exp Toxicol; 2013 Oct; 32(10):1089-96. PubMed ID: 23515495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of low-dose dual blockade of renin-angiotensin system on urinary TGF-beta in type 2 diabetic patients with advanced kidney disease.
    Song JH; Cha SH; Lee HJ; Lee SW; Park GH; Lee SW; Kim MJ
    Nephrol Dial Transplant; 2006 Mar; 21(3):683-9. PubMed ID: 16330466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of transforming growth factor-beta1 in diabetic kidney disease.
    Hellmich B; Schellner M; Schatz H; Pfeiffer A
    Metabolism; 2000 Mar; 49(3):353-9. PubMed ID: 10726914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The renal transcriptome of db/db mice identifies putative urinary biomarker proteins in patients with type 2 diabetes: a pilot study.
    Simonson MS; Tiktin M; Debanne SM; Rahman M; Berger B; Hricik D; Ismail-Beigi F
    Am J Physiol Renal Physiol; 2012 Apr; 302(7):F820-9. PubMed ID: 22205226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral supplementation of turmeric attenuates proteinuria, transforming growth factor-β and interleukin-8 levels in patients with overt type 2 diabetic nephropathy: a randomized, double-blind and placebo-controlled study.
    Khajehdehi P; Pakfetrat M; Javidnia K; Azad F; Malekmakan L; Nasab MH; Dehghanzadeh G
    Scand J Urol Nephrol; 2011 Nov; 45(5):365-70. PubMed ID: 21627399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.